Fred Schwarzer - Mar 12, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Mar 12, 2022
Transactions value $
$0
Form type
4
Date filed
3/15/2022, 08:53 PM
Previous filing
Nov 17, 2021
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +350K $0.00 350K Mar 12, 2022 Common Stock 350K $17.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48 of the shares subject to the option shall vest on April 12, 2022 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.